{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:56:26Z","timestamp":1790189786861,"version":"4.1.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Muscle resident fibro-adipogenic progenitors (FAPs), support muscle regeneration by releasing cytokines that stimulate the differentiation of myogenic stem cells. However, in non-physiological contexts (myopathies, atrophy, aging) FAPs cause fibrotic and fat infiltrations that impair muscle function. We set out to perform a fluorescence microscopy-based screening to identify compounds that perturb the differentiation trajectories of these multipotent stem cells. From a primary screen of 1,120 FDA\/EMA approved drugs, we identified 34 compounds as potential inhibitors of adipogenic differentiation of FAPs isolated from the murine model (\n                    <jats:italic>mdx<\/jats:italic>\n                    ) of Duchenne muscular dystrophy (DMD). The hit list from this screen was surprisingly enriched with compounds from the glucocorticoid (GCs) chemical class, drugs that are known to promote adipogenesis\n                    <jats:italic>in vitro<\/jats:italic>\n                    and\n                    <jats:italic>in vivo<\/jats:italic>\n                    . To shed light on these data, three GCs identified in our screening efforts were characterized by different approaches. We found that like dexamethasone, budesonide inhibits adipogenesis induced by insulin in sub-confluent FAPs. However, both drugs have a pro-adipogenic impact when the adipogenic mix contains factors that increase the concentration of cAMP. Gene expression analysis demonstrated that treatment with glucocorticoids induces the transcription of Gilz\/Tsc22d3, an inhibitor of the adipogenic master regulator PPAR\u03b3, only in anti-adipogenic conditions. Additionally, alongside their anti-adipogenic effect, GCs are shown to promote terminal differentiation of satellite cells. Both the anti-adipogenic and pro-myogenic effects are mediated by the glucocorticoid receptor and are not observed in the presence of receptor inhibitors. Steroid administration currently represents the standard treatment for DMD patients, the rationale being based on their anti-inflammatory effects. The findings presented here offer new insights on additional glucocorticoid effects on muscle stem cells that may affect muscle homeostasis and physiology.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-62194-6","type":"journal-article","created":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T07:06:27Z","timestamp":1585033587000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Janus effect of glucocorticoids on differentiation of muscle fibro\/adipogenic progenitors"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6907-5364","authenticated-orcid":false,"given":"Andrea","family":"Cerquone Perpetuini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4648-0076","authenticated-orcid":false,"given":"Giulio","family":"Giuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5333-7502","authenticated-orcid":false,"given":"Alessio","family":"Reggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Cerretani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisabella","family":"Santoriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Stefanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1300-5479","authenticated-orcid":false,"given":"Alessandro","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Vumbaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Castagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4491-603X","authenticated-orcid":false,"given":"Alberto","family":"Bresciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9528-6018","authenticated-orcid":false,"given":"Gianni","family":"Cesareni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,24]]},"reference":[{"key":"62194_CR1","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.biocel.2008.08.033","volume":"41","author":"C Mozzetta","year":"2009","unstructured":"Mozzetta, C., Minetti, G. & Puri, P. L. Regenerative pharmacology in the treatment of genetic diseases: the paradigm of muscular dystrophy. Int. J. Biochem. Cell Biol. 41, 701\u2013710 (2009).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"62194_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/B978-0-12-385940-2.00007-3","volume":"96","author":"AL Serrano","year":"2011","unstructured":"Serrano, A. L. et al. Cellular and molecular mechanisms regulating fibrosis in skeletal muscle repair and disease. Curr. Top. developmental Biol. 96, 167\u2013201 (2011).","journal-title":"Curr. Top. developmental Biol."},{"key":"62194_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/ncb2015","volume":"12","author":"AWB Joe","year":"2010","unstructured":"Joe, A. W. B. et al. Muscle injury activates resident fibro\/adipogenic progenitors that facilitate myogenesis. Nat. Cell Biol. 12, 153\u2013163 (2010).","journal-title":"Nat. Cell Biol."},{"key":"62194_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/ncb2014","volume":"12","author":"A Uezumi","year":"2010","unstructured":"Uezumi, A., Fukada, S., Yamamoto, N., Takeda, S. & Tsuchida, K. Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat. Cell Biol. 12, 143\u2013152 (2010).","journal-title":"Nat. Cell Biol."},{"key":"62194_CR5","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cell.2013.02.053","volume":"153","author":"JE Heredia","year":"2013","unstructured":"Heredia, J. E. et al. Type 2 Innate Signals Stimulate Fibro\/Adipogenic Progenitors to Facilitate Muscle Regeneration. CELL 153, 376\u2013388 (2013).","journal-title":"CELL"},{"key":"62194_CR6","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1242\/jcs.086629","volume":"124","author":"A Uezumi","year":"2011","unstructured":"Uezumi, A. et al. Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle. J. Cell Sci. 124, 3654\u20133664 (2011).","journal-title":"J. Cell Sci."},{"key":"62194_CR7","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.nmd.2016.07.002","volume":"26","author":"P Bettica","year":"2016","unstructured":"Bettica, P. et al. Histological effects of givinostat in boys with Duchenne muscular dystrophy. Neuromuscul. Disord. 26, 643\u2013649 (2016).","journal-title":"Neuromuscul. Disord."},{"key":"62194_CR8","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/emmm.201202096","volume":"5","author":"C Mozzetta","year":"2013","unstructured":"Mozzetta, C. et al. Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice. EMBO Mol. Med. 5, 626\u2013639 (2013).","journal-title":"EMBO Mol. Med."},{"key":"62194_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4161\/org.6.1.11293","volume":"6","author":"V Saccone","year":"2010","unstructured":"Saccone, V., Puri, P. L. & Lorenzo Puri, P. Epigenetic regulation of skeletal myogenesis. Organogenesis 6, 1\u20136 (2010).","journal-title":"Organogenesis"},{"key":"62194_CR10","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1101\/gad.234468.113","volume":"28","author":"V Saccone","year":"2014","unstructured":"Saccone, V. et al. HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles. Genes. Dev. 28, 841\u2013857 (2014).","journal-title":"Genes. Dev."},{"key":"62194_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cmet.2010.07.008","volume":"12","author":"D Cacchiarelli","year":"2010","unstructured":"Cacchiarelli, D. et al. MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin\/nNOS pathway. Cell Metab. 12, 341\u2013351 (2010).","journal-title":"Cell Metab."},{"key":"62194_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/emboj.2011.391","volume":"31","author":"SV Forcales","year":"2012","unstructured":"Forcales, S. V. et al. Signal-dependent incorporation of MyoD\u2013BAF60c into Brg1-based SWI\/SNF chromatin-remodelling complex. EMBO J. 31, 301\u2013316 (2012).","journal-title":"EMBO J."},{"key":"62194_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.coph.2017.04.002","volume":"34","author":"S Guiraud","year":"2017","unstructured":"Guiraud, S. & Davies, K. E. Pharmacological advances for treatment in Duchenne muscular dystrophy. Curr. Opin. Pharmacology 34, 36\u201348 (2017).","journal-title":"Curr. Opin. Pharmacology"},{"key":"62194_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/15216540400009968","volume":"56","author":"JT Tansey","year":"2004","unstructured":"Tansey, J. T., Sztalryd, C., Hlavin, E. M., Kimmel, A. R. & Londos, C. The central role of perilipin a in lipid metabolism and adipocyte lipolysis. IUBMB Life 56, 379\u2013385 (2004).","journal-title":"IUBMB Life"},{"key":"62194_CR15","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/ijo.2011.113","volume":"36","author":"A Girousse","year":"2012","unstructured":"Girousse, A. & Langin, D. Adipocyte lipases and lipid droplet-associated proteins: insight from transgenic mouse models. Int. J. Obes. 36, 581\u2013594 (2012).","journal-title":"Int. J. Obes."},{"key":"62194_CR16","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.chembiol.2012.06.012","volume":"19","author":"Y Wang","year":"2012","unstructured":"Wang, Y. et al. Glucocorticoid Compounds Modify Smoothened Localization and Hedgehog Pathway Activity. Chem. amp; Biol. 19, 972\u2013982 (2012).","journal-title":"Chem. amp; Biol."},{"key":"62194_CR17","doi-asserted-by":"publisher","first-page":"e0144550","DOI":"10.1371\/journal.pone.0144550","volume":"10","author":"G Porcu","year":"2015","unstructured":"Porcu, G. et al. Clobetasol and Halcinonide Act as Smoothened Agonists to Promote Myelin Gene Expression and RxR\u03b3 Receptor Activation. PLoS one 10, e0144550 (2015).","journal-title":"PLoS one"},{"key":"62194_CR18","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/0092-8674(94)90006-X","volume":"79","author":"P Tontonoz","year":"1994","unstructured":"Tontonoz, P., Hu, E. & Spiegelman, B. M. Stimulation of adipogenesis in fibroblasts by PPAR\u03b32, a lipid-activated transcription factor. Cell 79, 1147\u20131156 (1994).","journal-title":"Cell"},{"key":"62194_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.cellbio.16.1.145","volume":"16","author":"ED Rosen","year":"2000","unstructured":"Rosen, E. D. & Spiegelman, B. M. Molecular Regulation of Adipogenesis. Annu. Rev. Cell Developmental Biol. 16, 145\u2013171 (2000).","journal-title":"Annu. Rev. Cell Developmental Biol."},{"key":"62194_CR20","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nrm2066","volume":"7","author":"ED Rosen","year":"2006","unstructured":"Rosen, E. D. & MacDougald, O. A. Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell Biol. 7, 885\u2013896 (2006).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"62194_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1152\/physrev.00043.2011","volume":"93","author":"H Yin","year":"2013","unstructured":"Yin, H., Price, F. & Rudnicki, M. A. Satellite Cells and the Muscle Stem Cell Niche. Physiological Rev. 93, 23\u201367 (2013).","journal-title":"Physiological Rev."},{"key":"62194_CR22","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1083\/jcb.9.2.493","volume":"9","author":"A Mauro","year":"1961","unstructured":"Mauro, A. Satellite cell of skeletal muscle fibers. J. biophysical biochemical cytology 9, 493\u2013495 (1961).","journal-title":"J. biophysical biochemical cytology"},{"key":"62194_CR23","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.jaci.2013.09.007","volume":"132","author":"RH Oakley","year":"2013","unstructured":"Oakley, R. H. & Cidlowski, J. A. The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J. Allergy Clin. Immunol. 132, 1033\u20131044 (2013).","journal-title":"J. Allergy Clin. Immunol."},{"key":"62194_CR24","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/ncprheum0898","volume":"4","author":"C Stahn","year":"2008","unstructured":"Stahn, C. & Buttgereit, F. Genomic and nongenomic effects of glucocorticoids. Nat. Clin. Pract. Rheumatol. 4, 525\u2013533 (2008).","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"62194_CR25","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/j.1460-2075.1984.tb01879.x","volume":"3","author":"S Bourgeois","year":"1984","unstructured":"Bourgeois, S., Pfahl, M. & Baulieu, E. E. DNA binding properties of glucocorticosteroid receptors bound to the steroid antagonist RU-486. EMBO J. 3, 751\u2013755 (1984).","journal-title":"EMBO J."},{"key":"62194_CR26","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/324686a0","volume":"324","author":"PB Becker","year":"1986","unstructured":"Becker, P. B., Gloss, B., Schmid, W., Str\u00e4hle, U. & Sch\u00fctz, G. In vivo protein-DNA interactions in a glucocorticoid response element require the presence of the hormone. Nature 324, 686\u2013688 (1986).","journal-title":"Nature"},{"key":"62194_CR27","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.1128\/MCB.00709-07","volume":"28","author":"RK Petersen","year":"2008","unstructured":"Petersen, R. K. et al. Cyclic AMP (cAMP)-Mediated Stimulation of Adipocyte Differentiation Requires the Synergistic Action of Epac- and cAMP-Dependent Protein Kinase-Dependent Processes. Mol. Cell. Biol. 28, 3804\u20133816 (2008).","journal-title":"Mol. Cell. Biol."},{"key":"62194_CR28","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/00029330-200604010-00012","volume":"119","author":"L Yin","year":"2006","unstructured":"Yin, L., Li, Y. & Wang, Y. Dexamethasone-induced adipogenesis in primary marrow stromal cell cultures: mechanism of steroid-induced osteonecrosis. Chin. Med. J. 119, 581\u2013588 (2006).","journal-title":"Chin. Med. J."},{"key":"62194_CR29","doi-asserted-by":"publisher","first-page":"49776","DOI":"10.1074\/jbc.M207913200","volume":"277","author":"JW Neal","year":"2002","unstructured":"Neal, J. W. & Clipstone, N. A. Calcineurin mediates the calcium-dependent inhibition of adipocyte differentiation in 3T3-L1 cells. J. Biol. Chem. 277, 49776\u201381 (2002).","journal-title":"J. Biol. Chem."},{"key":"62194_CR30","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1210\/me.2008-0464","volume":"23","author":"C Xu","year":"2009","unstructured":"Xu, C. et al. Direct Effect of Glucocorticoids on Lipolysis in Adipocytes. Mol. Endocrinol. 23, 1161\u20131170 (2009).","journal-title":"Mol. Endocrinol."},{"key":"62194_CR31","doi-asserted-by":"publisher","first-page":"3769","DOI":"10.1096\/fj.14-251165","volume":"28","author":"S Perez-Diaz","year":"2014","unstructured":"Perez-Diaz, S. et al. Polymerase I and transcript release factor (PTRF) regulates adipocyte differentiation and determines adipose tissue expandability. FASEB J. 28, 3769\u20133779 (2014).","journal-title":"FASEB J."},{"key":"62194_CR32","doi-asserted-by":"publisher","first-page":"4128","DOI":"10.1128\/MCB.16.8.4128","volume":"16","author":"Z Wu","year":"1996","unstructured":"Wu, Z., Bucher, N. L. & Farmer, S. R. Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C\/EBPbeta, C\/EBPdelta, and glucocorticoids. Mol. Cell Biol. 16, 4128\u20134136 (1996).","journal-title":"Mol. Cell Biol."},{"key":"62194_CR33","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357 (2009).","journal-title":"Nat. Protoc."},{"key":"62194_CR34","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1172\/JCI30724","volume":"117","author":"E Ayroldi","year":"2007","unstructured":"Ayroldi, E. et al. GILZ mediates the antiproliferative activity of glucocorticoids by negative regulation of Ras signaling. J. Clin. Invest. 117, 1605\u20131615 (2007).","journal-title":"J. Clin. Invest."},{"key":"62194_CR35","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1182\/blood-2002-02-0538","volume":"101","author":"D Berrebi","year":"2003","unstructured":"Berrebi, D. et al. Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. Blood 101, 729\u2013738 (2003).","journal-title":"Blood"},{"key":"62194_CR36","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/sj.embor.embor805","volume":"4","author":"X Shi","year":"2003","unstructured":"Shi, X. et al. A glucocorticoid-induced leucine-zipper protein, GILZ, inhibits adipogenesis of mesenchymal cells. EMBO Rep. 4, 374\u2013380 (2003).","journal-title":"EMBO Rep."},{"key":"62194_CR37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/bioinformatics\/btr625","volume":"28","author":"EY Chen","year":"2012","unstructured":"Chen, E. Y. et al. Expression2Kinases: mRNA profiling linked to multiple upstream regulatory layers. Bioinformatics 28, 105\u2013111 (2012).","journal-title":"Bioinformatics"},{"key":"62194_CR38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fphys.2014.00068","volume":"5","author":"A Uezumi","year":"2014","unstructured":"Uezumi, A., Ikemoto-Uezumi, M. & Tsuchida, K. Roles of nonmyogenic mesenchymal progenitors in pathogenesis and regeneration of skeletal muscle. Front. Physiol. 5, 68\u201368 (2014).","journal-title":"Front. Physiol."},{"key":"62194_CR39","doi-asserted-by":"crossref","unstructured":"Reggio, A. et al. The immunosuppressant drug azathioprine restrains adipogenesis of muscle Fibro\/Adipogenic Progenitors from dystrophic mice by affecting AKT signaling. Scientific Reports 9(1) (2019).","DOI":"10.1038\/s41598-019-39538-y"},{"issue":"3","key":"62194_CR40","doi-asserted-by":"publisher","first-page":"e202000646","DOI":"10.26508\/lsa.202000660","volume":"3","author":"A Reggio","year":"2020","unstructured":"Reggio, A. et al. Metabolic reprogramming of fibro\/adipogenic progenitors facilitates muscle regeneration. Life Science Alliance 3(3), e202000646 (2020).","journal-title":"Life Science Alliance"},{"key":"62194_CR41","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00198-004-1649-7","volume":"16","author":"X Li","year":"2005","unstructured":"Li, X., Jin, L., Cui, Q., Wang, G.-J. & Balian, G. Steroid effects on osteogenesis through mesenchymal cell gene expression. Osteoporos. Int. 16, 101\u2013108 (2005).","journal-title":"Osteoporos. Int."},{"key":"62194_CR42","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby, K. et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 9, 77\u201393 (2010).","journal-title":"Lancet Neurol."},{"key":"62194_CR43","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby, K. et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol. 9, 177\u2013189 (2010).","journal-title":"Lancet Neurol."},{"key":"62194_CR44","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1212\/WNL.0000000000002337","volume":"86","author":"D Gloss","year":"2016","unstructured":"Gloss, D., Moxley, R. T., Ashwal, S. & Oskoui, M. Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 86, 465\u2013472 (2016).","journal-title":"Neurology"},{"key":"62194_CR45","first-page":"203","volume":"14","author":"W Ericson-Neilsen","year":"2017","unstructured":"Ericson-Neilsen, W. & Kaye, A. D. Steroids: pharmacology, complications, Pract. delivery issues. Ochsner J. vol. 14, 203\u2013207 (2017).","journal-title":"Steroids: pharmacology, complications, Pract. delivery issues. Ochsner J. vol."},{"key":"62194_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI91445","volume":"127","author":"M Quattrocelli","year":"2017","unstructured":"Quattrocelli, M. et al. Intermittent glucocorticoid steroid dosing enhances muscle repair without eliciting muscle atrophy. J. Clin. Invest. 127, 1\u201315 (2017).","journal-title":"J. Clin. Invest."},{"key":"62194_CR47","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.steroids.2017.11.002","volume":"133","author":"RS Sulaiman","year":"2018","unstructured":"Sulaiman, R. S., Kadmiel, M. & Cidlowski, J. A. Glucocorticoid receptor signaling in the eye. Steroids 133, 60\u201366 (2018).","journal-title":"Steroids"},{"key":"62194_CR48","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/art.21984","volume":"55","author":"JR Curtis","year":"2006","unstructured":"Curtis, J. R. et al. Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum. 55, 420\u2013426 (2006).","journal-title":"Arthritis Rheum."},{"key":"62194_CR49","first-page":"CD003725","volume":"17","author":"E Matthews","year":"2016","unstructured":"Matthews, E., Brassington, R., Kuntzer, T., Jichi, F. & Manzur, A. Y. Corticosteroids for the treatment of Duchenne muscular dystrophy. Cochrane Database Syst. Rev. 17, CD003725\u2013CD003725 (2016).","journal-title":"Cochrane Database Syst. Rev."},{"key":"62194_CR50","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jpeds.2016.11.078","volume":"182","author":"BL Wong","year":"2017","unstructured":"Wong, B. L. et al. Long-Term Outcome of Interdisciplinary Management of Patients with Duchenne Muscular Dystrophy Receiving Daily Glucocorticoid Treatment. J. Pediatr. 182, 296\u2013303.e1 (2017).","journal-title":"J. Pediatr."},{"issue":"Suppl 1","key":"62194_CR51","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.1016\/S0960-8966(02)00101-3","volume":"12","author":"F Muntoni","year":"2002","unstructured":"Muntoni, F., Fisher, I., Morgan, J. E. & Abraham, D. Steroids in Duchenne muscular dystrophy: from clinical trials to genomic research. Neuromuscul. Disord. 12(Suppl 1), S162\u20135 (2002).","journal-title":"Neuromuscul. Disord."},{"key":"62194_CR52","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1517\/21678707.2016.1130617","volume":"4","author":"M Sandona","year":"2016","unstructured":"Sandona, M., Consalvi, S., Tucciarone, L., Puri, P. L. & Saccone, V. HDAC inhibitors for muscular dystrophies: progress and prospects. Expert. Opin. Orphan Drugs 4, 125\u2013127 (2016).","journal-title":"Expert. Opin. Orphan Drugs"},{"key":"62194_CR53","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.molmed.2012.04.005","volume":"18","author":"P Moutsatsou","year":"2012","unstructured":"Moutsatsou, P., Kassi, E. & Papavassiliou, A. G. Glucocorticoid receptor signaling in bone cells. Trends Mol. Med. 18, 348\u2013359 (2012).","journal-title":"Trends Mol. Med."},{"key":"62194_CR54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12860-015-0056-6","volume":"16","author":"O Ghali","year":"2015","unstructured":"Ghali, O. et al. Dexamethasone in osteogenic medium strongly induces adipocyte differentiation of mouse bone marrow stromal cells and increases osteoblast differentiation. BMC Cell Biol. 16, 9\u201315 (2015).","journal-title":"BMC Cell Biol."},{"key":"62194_CR55","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1177\/1535370214566565","volume":"240","author":"D Contador","year":"2015","unstructured":"Contador, D. et al. Featured Article: Dexamethasone and rosiglitazone are sufficient and necessary for producing functional adipocytes from mesenchymal stem cells. Exp. Biol. Med. 240, 1235\u20131246 (2015).","journal-title":"Exp. Biol. Med."},{"key":"62194_CR56","doi-asserted-by":"publisher","first-page":"4723","DOI":"10.1074\/jbc.M704147200","volume":"283","author":"W Zhang","year":"2008","unstructured":"Zhang, W., Yang, N. & Shi, X.-M. Regulation of mesenchymal stem cell osteogenic differentiation by glucocorticoid-induced leucine zipper (GILZ). J. Biol. Chem. 283, 4723\u20134729 (2008).","journal-title":"J. Biol. Chem."},{"key":"62194_CR57","doi-asserted-by":"publisher","first-page":"10385","DOI":"10.1074\/jbc.M109.070136","volume":"285","author":"S Bruscoli","year":"2010","unstructured":"Bruscoli, S. et al. Glucocorticoid-induced leucine zipper (GILZ) and long GILZ inhibit myogenic differentiation and mediate anti-myogenic effects of glucocorticoids. J. Biol. Chem. 285, 10385\u201310396 (2010).","journal-title":"J. Biol. Chem."},{"key":"62194_CR58","doi-asserted-by":"publisher","first-page":"434","DOI":"10.7150\/ijms.18427","volume":"14","author":"D-S Han","year":"2017","unstructured":"Han, D.-S., Yang, W.-S. & Kao, T.-W. Dexamethasone Treatment at the Myoblast Stage Enhanced C2C12 Myocyte Differentiation. Int. J. Med. Sci. 14, 434\u2013443 (2017).","journal-title":"Int. J. Med. Sci."},{"key":"62194_CR59","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1210\/endo-106-4-1198","volume":"106","author":"V Guerriero","year":"1980","unstructured":"Guerriero, V. & Florini, J. R. Dexamethasone effects on myoblast proliferation and differentiation. Endocrinology 106, 1198\u20131202 (1980).","journal-title":"Endocrinology"},{"key":"62194_CR60","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/jnr.490350403","volume":"35","author":"AC Passaquin","year":"1993","unstructured":"Passaquin, A. C., Metzinger, L., L\u00e9ger, J. J., Warter, J. M. & Poindron, P. Prednisolone enhances myogenesis and dystrophin-related protein in skeletal muscle cell cultures from mdx mouse. J. Neurosci. Res. 35, 363\u2013372 (1993).","journal-title":"J. Neurosci. Res."},{"key":"62194_CR61","first-page":"921","volume":"49","author":"W Ding","year":"2014","unstructured":"Ding, W., Ding, L., Li, W.-B., Pan, H. & Lin, H.-D. Pharmacokinetics of deflazacort tablets in healthy Chinese volunteers. Yaoxue Xuebao 49, 921\u20136 (2014).","journal-title":"Yaoxue Xuebao"},{"key":"62194_CR62","first-page":"E67","volume":"268","author":"Z Rifai","year":"1995","unstructured":"Rifai, Z., Welle, S., Moxley, R. T., Lorenson, M. & Griggs, R. C. Effect of prednisone on protein metabolism in Duchenne dystrophy. Am. J. Physiol. 268, E67\u201374 (1995).","journal-title":"Am. J. Physiol."},{"key":"62194_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/JOE-07-0606","volume":"197","author":"O Schakman","year":"2008","unstructured":"Schakman, O., Gilson, H. & Thissen, J. P. Mechanisms of glucocorticoid-induced myopathy. J. Endocrinol. 197, 1\u201310 (2008).","journal-title":"J. Endocrinol."},{"key":"62194_CR64","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1182\/blood-2003-12-4295","volume":"104","author":"M-L Asselin-Labat","year":"2004","unstructured":"Asselin-Labat, M.-L. et al. GILZ, a new target for the transcription factor FoxO3, protects T lymphocytes from interleukin-2 withdrawal\u2013induced apoptosis. Blood 104, 215\u2013223 (2004).","journal-title":"Blood"},{"key":"62194_CR65","doi-asserted-by":"crossref","unstructured":"Pavlidou, T. et al. Metformin Delays Satellite Cell Activation and Maintains Quiescence. Stem Cells International https:\/\/www.hindawi.com\/journals\/sci\/2019\/5980465\/ doi:https:\/\/doi.org\/10.1155\/2019\/5980465 (2019).","DOI":"10.1155\/2019\/5980465"},{"key":"62194_CR66","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.4161\/cc.28401","volume":"13","author":"RA McCloy","year":"2014","unstructured":"McCloy, R. A. et al. Partial inhibition of Cdk1 in G 2phase overrides the SAC and decouples mitotic events. Cell Cycle 13, 1400\u20131412 (2014).","journal-title":"Cell Cycle"},{"key":"62194_CR67","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1083\/jcb.132.1.181","volume":"132","author":"S Yoshida","year":"1996","unstructured":"Yoshida, S., Fujisawa-Sehara, A., Taki, T., Arai, K. & Nabeshima, Y. Lysophosphatidic acid and bFGF control different modes in proliferating myoblasts. J. Cell Biol. 132, 181\u2013193 (1996).","journal-title":"J. Cell Biol."},{"key":"62194_CR68","unstructured":"Krueger, F. Trim galore. A wrapper tool around Cutadapt and FastQC to consistently apply quality and adapter trimming to FastQ files (2015)."},{"key":"62194_CR69","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"62194_CR70","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1101\/gr.229102","volume":"12","author":"WJ Kent","year":"2002","unstructured":"Kent, W. J. et al. The human genome browser at UCSC. Genome Res. 12, 996\u20131006 (2002).","journal-title":"Genome Res."},{"key":"62194_CR71","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq\u2013a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169 (2015).","journal-title":"Bioinformatics"},{"key":"62194_CR72","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"62194_CR73","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/jcsm.12303","volume":"9","author":"A Cerquone Perpetuini","year":"2018","unstructured":"Cerquone Perpetuini, A. et al. Group I Paks support muscle regeneration and counteract cancer-associated muscle atrophy. J. Cachexia Sarcopenia Muscle 9, 727\u2013746 (2018).","journal-title":"J. Cachexia Sarcopenia Muscle"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62194-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62194-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62194-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T03:53:56Z","timestamp":1670298836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62194-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,24]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["62194"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-62194-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/581363","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,24]]},"assertion":[{"value":"24 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors Andrea Cerquone Perpetuini, Giulio Giuliani, Alessio Reggio, Mauro Cerretani, Marisabella Santoriello, Roberta Stefanelli, Alessandro Palma, Simone Vumbaca, Steven Harper, Luisa Castagnoli, Alberto Bresciani and Gianni Cesareni declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5363"}}